Your search returned 1590 results.

Results
	1221.	Can patients with metastatic breast cancer be cured after introduction of newer and more effective agents? [electronic resource] by Ohno, Shinji Tanaka, Kimihiro Koga, Chinami Nishimura, Sumiko Yamaguchi, Hiroshi Kawaguchi, Hidetoshi Yoshiyama, Tomoyuki Nakamura, Yoshiaki Producer: 20130201 In: Breast cancer (Tokyo, Japan) vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1222.	Hints of future progress for HER-2 breast cancer. [electronic resource] by Twombly, Renee Producer: 20110531 In: Journal of the National Cancer Institute vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1223.	[Systemic treatment of brain metastases from breast cancer]. [electronic resource] by Taillibert, S Conforti, R Bonneterre, J Bachelot, T Le Rhun, E Bernard-Marty, C Producer: 20150501 In: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1224.	[Current possibilities of targeted therapy in the treatment of breast cancer with overexpression of HER-2/neu and metastatic lesions in the brain]. [electronic resource] by Naskhletashvili, D R Gorbunova, V A Moskvina, E A Producer: 20130927 In: Voprosy onkologii vol. 59 Availability: No items available. Save to lists Add to cart (remove)
	1225.	Acquired substrate preference for GAB1 protein bestows transforming activity to ERBB2 kinase lung cancer mutants. [electronic resource] by Fan, Ying-Xin Wong, Lily Marino, Michael P Ou, Wu Shen, Yi Wu, Wen Jin Wong, Kwok-Kin Reiser, Jakob Johnson, Gibbes R Producer: 20130812 In: The Journal of biological chemistry vol. 288 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1226.	Lapatinib and platinum-based chemotherapy ameliorate breast cancer with choroidal metastasis and restore visual acuity. [electronic resource] by Ju, Uei-Han Tsai, Ming-Ling Lin, Chun-Shu Chao, Tsu-Yi Dai, Ming-Shen Producer: 20141128 In: Tumori vol. 100 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1227.	The clinical utility of HER2-targeted therapy in the neoadjuvant setting: recent results from the San Antonio Breast Cancer Symposium. [electronic resource] by Abair, Tristin O'Shaughnessy, Joyce Producer: 20120126 In: Clinical breast cancer vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1228.	Retreatment with trastuzumab-based therapy after disease progression following lapatinib in HER2-positive metastatic breast cancer. [electronic resource] by Gori, S Montemurro, F Spazzapan, S Metro, G Foglietta, J Bisagni, G Ferzi, A Silva, R R Gamucci, T Clavarezza, M Stocchi, L Fabi, A Cognetti, F Torrisi, E Crivellari, D Producer: 20120920 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1229.	Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab. [electronic resource] by Nishimura, Reiki Toh, Uhi Tanaka, Maki Saimura, Michiyo Okumura, Yasuhiro Saito, Tsuyoshi Tanaka, Toshihiro Teraoka, Megumi Shimada, Kazuo Katayama, Kazuhisa Koga, Toshihiro Kurashita, Kaname Hasegawa, Satoshi Todoroki, Hidekazu Kai, Yuichiro Ohi, Yasuyo Toyoshima, Satoshi Arima, Nobuyuki Mitsuyama, Shoshu Tamura, Kazuo Producer: 20171018 In: Oncology vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1230.	Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial. [electronic resource] by Shi, W Jiang, T Nuciforo, P Hatzis, C Holmes, E Harbeck, N Sotiriou, C Peña, L Loi, S Rosa, D D Chia, S Wardley, A Ueno, T Rossari, J Eidtmann, H Armour, A Piccart-Gebhart, M Rimm, D L Baselga, J Pusztai, L Producer: 20180501 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1231.	Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials. [electronic resource] by Hao, Shuai Tian, Wuguo Gao, Bo Jiang, Yan Zhang, Xiaohua Zhang, Shu Guo, Lingji Zhao, Jianjie Zhang, Gang Hu, Chunyan Yan, Jie Luo, Donglin Producer: 20170831 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1232.	Cisplatin, Gemcitabine, and Lapatinib as Neoadjuvant Therapy for Muscle-Invasive Bladder Cancer. [electronic resource] by Narayan, Vivek Mamtani, Ronac Keefe, Stephen Guzzo, Thomas Malkowicz, S Bruce Vaughn, David J Producer: 20180205 In: Cancer research and treatment vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1233.	Early decline in serum phospho-CSE1L levels in vemurafenib/sunitinib-treated melanoma and sorafenib/lapatinib-treated colorectal tumor xenografts. [electronic resource] by Lee, Woan-Ruoh Shen, Shing-Chuan Shih, Yi-Hsien Chou, Chia-Lun Tseng, Jonathan Te-Peng Chin, Szu-Ying Liu, Kao-Hui Chen, Yen-Chou Jiang, Ming-Chung Producer: 20160314 In: Journal of translational medicine vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1234.	NRF2 Regulates HER1 Signaling Pathway to Modulate the Sensitivity of Ovarian Cancer Cells to Lapatinib and Erlotinib. [electronic resource] by Kankia, Ibrahim H Khalil, Hilal S Langdon, Simon P Moult, Peter R Bown, James L Deeni, Yusuf Y Producer: 20180821 In: Oxidative medicine and cellular longevity vol. 2017 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1235.	A multidisciplinary approach to the management of breast cancer, part 2: therapeutic considerations. [electronic resource] by Pruthi, Sandhya Boughey, Judy C Brandt, Kathleen R Degnim, Amy C Dy, Grace K Goetz, Matthew P Perez, Edith A Reynolds, Carol A Schomberg, Paula J Ingle, James N Producer: 20071012 In: Mayo Clinic proceedings vol. 82 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1236.	Treatment of breast cancer with trastuzumab during pregnancy. [electronic resource] by Pant, Shubham Landon, Mark B Blumenfeld, Michael Farrar, William Shapiro, Charles L Producer: 20080327 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1237.	FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2. [electronic resource] by Ryan, Qin Ibrahim, Amna Cohen, Martin H Johnson, John Ko, Chia-wen Sridhara, Rajeshwari Justice, Robert Pazdur, Richard Producer: 20090325 In: The oncologist vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1238.	A synergistic interaction between lapatinib and chemotherapy agents in a panel of cell lines is due to the inhibition of the efflux pump BCRP. [electronic resource] by Perry, Jackie Ghazaly, Essam Kitromilidou, Christiana McGrowder, Eva H Joel, Simon Powles, Thomas Producer: 20110328 In: Molecular cancer therapeutics vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1239.	Randomized study of Lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer. [electronic resource] by Blackwell, Kimberly L Burstein, Harold J Storniolo, Anna Maria Rugo, Hope Sledge, George Koehler, Maria Ellis, Catherine Casey, Michelle Vukelja, Svetislava Bischoff, Joachim Baselga, Jose O'Shaughnessy, Joyce Producer: 20100325 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	1240.	Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial. [electronic resource] by Baselga, José Bradbury, Ian Eidtmann, Holger Di Cosimo, Serena de Azambuja, Evandro Aura, Claudia Gómez, Henry Dinh, Phuong Fauria, Karine Van Dooren, Veerle Aktan, Gursel Goldhirsch, Aron Chang, Tsai-Wang Horváth, Zsolt Coccia-Portugal, Maria Domont, Julien Tseng, Ling-Min Kunz, Georg Sohn, Joo Hyuk Semiglazov, Vladimir Lerzo, Guillermo Palacova, Marketa Probachai, Volodymyr Pusztai, Lajos Untch, Michael Gelber, Richard D Piccart-Gebhart, Martine Producer: 20120305 In: Lancet (London, England) vol. 379 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1590 results.